Stay updated on Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Updated version to v3.0.2 and removed the 'Back to Top' link; no other substantial content changes detected.
    Difference
    0.2%
    Check dated 2025-09-14T22:08:45.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new revision version (v3.0.1) and has removed an older date (2025-08-13).
    Difference
    0.5%
    Check dated 2025-09-07T19:10:41.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and country listings. These changes enhance the clarity and relevance of the page's content.
    Difference
    100%
    Check dated 2025-08-31T12:21:41.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated to a new version, v2.16.12, with the previous version, v2.16.11, being removed. The date has also changed from July 28, 2025, to August 13, 2025.
    Difference
    1.0%
    Check dated 2025-08-17T04:39:25.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-10T00:31:15.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has removed a service alert regarding planned maintenance and updated the revision history, indicating a transition from version v2.16.8 to v2.16.10.
    Difference
    4%
    Check dated 2025-08-01T18:54:08.000Z thumbnail image

Stay in the know with updates to Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.